Immunomodulatory application of engineered hydrogels in regenerative medicine
Source abstract
Abstract
Abstract With unique physicochemical properties such as high-water content, drug loading capacity, biodegradability, and biocompatibility, hydrogels are promising materials for biomedical applications. In addition, they can be designed into specific functionalities such as self-healing, injectable, shape memory, and stimuli-responsive. Based on above features, hydrogels hold great potential as biomaterials for regenerative medicine. On the other hand, immunobiology is a field that has experienced rapid development in the past few years. Hydrogels are three-dimensional (3D) polymer networks that have superior biocompatibility and therefore easy to be processed for immunoregulation. In this review we explore the role played by hydrogels in regenerative medicine, particularly with regards to their role in immunobiology, their effect of immunomodulation as well as regenerative efficacy. We believe these great achievements will provide valuable reference to choose ideal hydrogels for biomedical application, especially for the development of immunobiology.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Nerve injury and regeneration · Cellular Mechanics and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Minimal change disease: a “two-hit” podocyte immune disorder?10.1007/s00467-010-1676-x ↗
2. Diabetic nephropathy – is this an immune disorder?10.1042/CS20160636 ↗
3. Osteoporosis: a bone morphogenetic protein auto-immune disorder
4. A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice10.1038/srep13155 ↗
5. Advances in targeting cell surface signalling molecules for immune modulation10.1038/nrd3877 ↗
6. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies10.1038/nbt1267 ↗
7. Nucleoside analogs as chemotherapeutic-agents – a review10.1080/07328319208021748 ↗
8. Vaccine adjuvants: putting innate immunity to work10.1016/j.immuni.2010.10.002 ↗
9. The impact of the extracellular matrix on inflammation10.1038/nri2852 ↗
10. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes10.1038/nm.2262 ↗
11. From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis10.1038/nm0307-295 ↗
12. Hybrid cross-linking characteristics of hydrogel control stem cell fate10.1002/mabi.201400535 ↗
13. Designing biomaterials to direct stem cell fate10.1021/nn304773b ↗
14. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate10.1038/nmat2732 ↗
15. Materials as stem cell regulators10.1038/nmat3937 ↗
16. Fabrication of a micellar supramolecular hydrogel for ocular drug delivery10.1021/acs.biomac.5b01526 ↗
17. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery10.1016/j.jconrel.2016.02.012 ↗
18. Photopolymerizable platelet lysate hydrogels for customizable 3D cell culture platforms10.1002/adhm.201800849 ↗
19. The role of the adaptive immune system in regulation of gut microbiota10.1111/imr.12185 ↗
20. The interface between innate and adaptive immunity10.1038/ni1004-971 ↗
21. Innate immune recognition: mechanisms and pathways10.1034/j.1600-065X.2000.917309.x ↗
22. Dendritic cells as therapeutic adjuncts in surgical disease10.1016/j.surg.2005.02.003 ↗
23. Effect of dietary nickel chloride on splenic immune function in broilers10.1007/s12011-014-0003-y ↗
24. Katz · 1972 · vol. 15 · 1
25. Cellular immunity and the homograft reaction10.1093/oxfordjournals.bmb.a070517 ↗
26. Associative learning in biochemical networks10.1016/j.jtbi.2007.07.004 ↗
27. Differentiation of memory B and T cells10.1016/j.coi.2006.03.020 ↗
28. Taking dendritic cells into medicine10.1038/nature06175 ↗
29. Dendritic cells: specialized and regulated antigen processing machines10.1016/S0092-8674(01)00449-4 ↗
30. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity10.1016/j.immuni.2011.05.006 ↗
31. Toll-like receptors and antibody responses10.1038/nature04875 ↗
32. Toll-like receptors and cancer10.1038/nrc2541 ↗
33. Advances in engineering hydrogels10.1126/science.aaf3627 ↗
34. Tough adhesive and self-healing conductive 3D network hydrogel of physically linked functionalized-boron nitride/clay/poly(N-isopropylacrylamide)10.1039/C7TA10898B ↗
35. Mussel-inspired adhesive and conductive hydrogel with long-lasting moisture and extreme temperature tolerance10.1002/adfm.201704195 ↗
36. Glucose-sensitive hydrogel optical fibers functionalized with phenylboronic acid10.1002/adma.201606380 ↗
37. Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms10.1073/pnas.1305000110 ↗
38. Novel vaccine adjuvant LPS-Hydrogel for truncated basic fibroblast growth factor to induce antitumor immunity10.1016/j.carbpol.2012.03.073 ↗
39. Effects of 3D culturing conditions on the transcriptomic profile of stem-cell-derived neurons10.1038/s41551-018-0219-9 ↗
40. Salecan-based pH-sensitive hydrogels for insulin delivery10.1021/acs.molpharmaceut.6b00875 ↗
41. Tough bonding of hydrogels to diverse non-porous surfaces10.1038/nmat4463 ↗
42. An injectable self-assembling collagen-gold hybrid hydrogel for combinatorial antitumor photothermal/photodynamic therapy10.1002/adma.201600284 ↗
43. Design of Salecan-containing semi-IPN hydrogel for amoxicillin delivery10.1016/j.msec.2017.02.089 ↗
44. Anionic and cationic dextran hydrogels for post-loading and release of proteins10.1016/j.jconrel.2010.11.027 ↗
45. Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment10.1038/nmat4497 ↗
46. Hydrogel doped with nanoparticles for local sustained release of siRNA in breast cancer10.1002/adhm.201400235 ↗
47. Functionalization, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular tissue culture platforms10.1038/nprot.2016.037 ↗
48. 3D Bioprinting of low-concentration cell-laden gelatin methacrylate (GelMA) bioinks with a two-step cross-linking strategy10.1021/acsami.7b16059 ↗
49. Photocrosslinkable gelatin hydrogel for epidermal tissue engineering10.1002/adhm.201500005 ↗
50. Elastin-like protein-hyaluronic acid (ELP-HA) hydrogels with decoupled mechanical and biochemical cues for cartilage regeneration10.1016/j.biomaterials.2017.02.010 ↗
51. Preparation, characterization, and biocompatibility evaluation of poly(Nvarepsilon-acryloyl-l-lysine)/hyaluronic acid interpenetrating network hydrogels10.1016/j.carbpol.2015.09.095 ↗
52. Poly(ethylene glycol) diacrylate/hyaluronic acid semi-interpenetrating network compositions for 3-D cell spreading and migration10.1016/j.actbio.2014.12.007 ↗
53. Injectable silk-polyethylene glycol hydrogels10.1016/j.actbio.2014.10.027 ↗
54. Tough adhesives for diverse wet surfaces10.1126/science.aah6362 ↗
55. Creating stiffness gradient polyvinyl alcohol hydrogel using a simple gradual freezing-thawing method to investigate stem cell differentiation behaviors10.1016/j.biomaterials.2014.11.017 ↗
56. Investigation of Salecan/poly(vinyl alcohol) hydrogels prepared by freeze/thaw method10.1016/j.carbpol.2014.11.021 ↗
57. Engineered hydrogels for local and sustained delivery of RNA-interference therapies10.1002/adhm.201601041 ↗
58. Hydrogels for therapeutic delivery: current developments and future directions10.1021/acs.biomac.6b01604 ↗
59. Highly elastic and conductive human-based protein hybrid hydrogels10.1002/adma.201503255 ↗
60. Fabrication and characterization of a novel anticancer drug delivery system: salecan/poly(methacrylic acid) semi-interpenetrating polymer network hydrogel10.1021/acsbiomaterials.5b00346 ↗
61. Weak hydrogen bonding enables hard, strong tough, and elastic hydrogels10.1002/adma.201503724 ↗
62. Tough and biocompatible hydrogels based on in situ interpenetrating networks of dithiol-connected graphene oxide and poly(vinyl alcohol)10.1021/acsami.5b00184 ↗
63. Oppositely charged polyelectrolytes form tough, self-healing, and rebuildable hydrogels10.1002/adma.201500140 ↗
64. Self-assembling DNA hydrogel-based delivery of immunoinhibitory nucleic acids to immune cells10.1016/j.nano.2015.08.004 ↗
65. Injectable bioresponsive gel depot for enhanced immune checkpoint blockade10.1002/adma.201801527 ↗
66. Mediating the invasion of smooth muscle cells into a cell-responsive hydrogel under the existence of immune cells10.1016/j.biomaterials.2018.07.022 ↗
67. Engineering dendritic-cell-based vaccines and PD-1 blockade in self-assembled peptide nanofibrous hydrogel to amplify antitumor T-cell immunity10.1021/acs.nanolett.8b01406 ↗
68. Injectable hydrogels coencapsulating granulocyte-macrophage colony-stimulating factor and ovalbumin nanoparticles to enhance antigen uptake efficiency10.1021/acsami.8b04312 ↗
69. Murphy · 2016
70. Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation10.1016/j.biomaterials.2009.09.045 ↗
71. Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy10.1016/j.biomaterials.2008.05.033 ↗
72. Multicomponent injectable hydrogels for antigen-specific tolerogenic immune modulation10.1002/adhm.201600773 ↗
73. In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in mice10.1021/bm501166j ↗
74. An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma10.1016/j.jconrel.2011.06.008 ↗
75. In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells10.1016/j.biomaterials.2009.06.001 ↗
76. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer10.1016/S0022-5347(17)45606-0 ↗
77. Systemic bacillus Calmette-Guerin (BCG) activates natural suppressor cells10.1073/pnas.75.10.5142 ↗
78. A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette-Guerin in the treatment of bladder cancer10.1016/j.biomaterials.2013.09.027 ↗
79. Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration10.1002/jbm.a.31661 ↗
80. A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection10.1016/j.jconrel.2008.07.025 ↗
81. Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization10.1016/j.vaccine.2012.10.033 ↗
82. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat10.1016/j.jconrel.2010.05.012 ↗
83. Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques10.1038/mi.2015.5 ↗
84. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells10.4049/jimmunol.1001875 ↗
85. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines10.1038/nmat2784 ↗
86. Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities10.1097/TP.0b013e31820263b3 ↗
87. Tolerogenic dendritic cells and the quest for transplant tolerance10.1038/nri2132 ↗
88. Injectable pore-forming hydrogels for in vivo enrichment of immature dendritic cells10.1002/adhm.201500618 ↗
89. Strategies to reduce dendritic cell activation through functional biomaterial design10.1016/j.biomaterials.2012.02.009 ↗
90. Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL- or IL-3 ameliorates murine collagen-induced arthritis (CIA)10.1046/j.1365-2249.1999.00959.x ↗
91. The effect of targeted delivery of anti-TNF-alpha oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice10.1016/j.biomaterials.2012.06.074 ↗
92. Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets10.1021/bc060023o ↗
93. Human limbal niche cells are a powerful regenerative source for the prevention of limbal stem cell deficiency in a rabbit model10.1038/s41598-018-24862-6 ↗
94. Knockdown of MicroRNA Let-7a improves the functionality of bone marrow-derived mesenchymal stem cells in immunotherapy10.1016/j.ymthe.2016.11.015 ↗
95. An overlooked tumor promoting immunoregulation by non-hematopoietic stromal cells10.1016/j.imlet.2016.06.002 ↗
96. Immunobiology of mesenchymal stem cells10.1038/cdd.2013.158 ↗
97. Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications10.1002/cyto.a.22402 ↗
98. PI3kalpha and STAT1 interplay regulates human mesenchymal stem cell immune polarization10.1002/stem.1986 ↗
99. Mesenchymal stem cells: immune evasive, not immune privileged10.1038/nbt.2816 ↗
100. Preserving prostaglandin E2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores postinfarction ventricular function10.1161/CIRCULATIONAHA.112.000324 ↗